ORLANDO, Fla. — The Orlando VA Healthcare System is using a new kind of therapy to provide mental health treatment for some veterans for whom traditional treatment isn’t effective. The treatment, ...

This week, the FDA approved esketamine, the first nasal spray to treat depression in adults who have tried other antidepressant medications without success. Esketamine, which the FDA approved to be ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Esketamine nasal ...

For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone ...

Shown here is Spravato, the branded version of the chemical known as esketamine. First approved in 2019 as an add-on treatment for depression, esketamine received expanded federal approval last month ...

Please provide your email address to receive an email when new articles are posted on . If this indication of esketamine is approved, it would be the first monotherapy for treatment-resistant ...

TITUSVILLE, N.J., Jan. 21, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for ...

A phase 3 clinical trial testing esketamine nasal spray in the treatment of severe depression found the spray mostly safe and effective. The findings led to the recent FDA approval of this treatment.

Please provide your email address to receive an email when new articles are posted on . At 7 days postpartum, esketamine was associated with significantly lower depressive symptom prevalence vs.